Meenakshi Mission Hospital
About Meenakshi Mission Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Piramal Enterprises Limited
3
Daiichi Sankyo, Inc.
2
Dr. Reddy's Laboratories Limited
2
Karyopharm Therapeutics Inc
2
Boston Scientific Corporation
1
CEL-SCI Corporation
1
Eisai Pharmaceuticals India Pvt. Ltd
1
Jazz Pharmaceuticals
1
Mylan Pharmaceuticals Inc
1
Novartis
1
Puma Biotechnology, Inc.
1
Clinical Trials at Meenakshi Mission Hospital
During the past decade, Meenakshi Mission Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.
2007-11-01
2010-01-01
Completed
360
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
2008-01-01
2010-11-01
Terminated
137
Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)
2008-09-01
2011-04-01
Completed
349
Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer
2008-12-01
2012-08-01
Completed
111
Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer
2009-08-01
2012-11-01
Completed
23
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
2009-08-21
2018-06-28
Completed
479
Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer
2010-03-01
2013-04-01
Completed
90
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
2010-12-01
2020-12-04
Completed
928
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Meenakshi Mission Hospital" #1 sponsor was "Piramal Enterprises Limited" with 3 trials, followed by "Daiichi Sankyo, Inc." with 2 trials
sponsored, "Dr. Reddy's Laboratories Limited" with 2 trials sponsored, "Karyopharm Therapeutics Inc" with 2 trials sponsored and "Boston Scientific Corporation"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Meenakshi Mission Hospital"
#1 collaborator was "Orient Europharma Co., Ltd." with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator, "Reliance Clinical Research Services (Navi Mumbai, India)" with 1 trials as a collaborator and "Teva Branded Pharmaceutical Products R&D, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Meenakshi Mission Hospital
According to Clinical.Site data, the most researched conditions in "Meenakshi Mission Hospital" are
"Advanced Refractory Solid Tumors" (2 trials), "Adenocarcinoma of the Esophagus" (1 trials), "Advanced Breast Cancer" (1 trials), "Advanced Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Meenakshi Mission Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Meenakshi Mission Hospital
Most popular intervention types in "Meenakshi Mission Hospital" are "Drug" (16 trials), "Radiation" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (2 trials), "Selinexor" (2 trials), "5-FU" (1 trials), "Bevacizumab as Avastin" (1 trials) and "Bevacizumab as MYL-1402O" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Meenakshi Mission Hospital
The vast majority of trials in "Meenakshi Mission Hospital" are
15 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Meenakshi Mission Hospital
Currently, there are NaN active trials in "Meenakshi Mission Hospital".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Meenakshi Mission Hospital,
2 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Meenakshi Mission Hospital, 5 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".